Large gap with delayed quotes
|
Last quote
02/28/2026
-
02:00:00
|
Bid
02/27/2026 -
21:59:59
|
Bid Volume |
Ask
02/27/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
73.43
-0.95
(
-1.28% )
|
73.41
|
800 |
73.42
|
300 |
Analysis date: 27.02.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 18.11.2025.
Interest
Very strong
Very strong
Four stars since 02.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 02.01.2026 at a price of 66.54.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 05.12.2025.
4wk Rel Perf
1.10%
1.10%
The four-week dividend-adjusted overperformance versus SP500 is 1.10%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 18.11.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.93%.
Mkt Cap in $bn
28.26
28.26
With a market capitalization >$8bn, DEXCOM is considered a large-cap stock.
G/PE Ratio
0.96
0.96
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
20.95
20.95
The estimated PE is for the year 2028.
LT Growth
20.06%
20.06%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
25
25
Over the last seven weeks, an average of 25 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
131
131
For 1% of index variation, the stock varies on average by 1.31%.
Correlation
0.54
0.54
53.78% of stock movements are explained by index variations.
Value at Risk
17.62
17.62
The value at risk is estimated at USD 17.62. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
06.04.2011
06.04.2011